Everyday Health names ABC News exec to lead video efforts

Share this article:
Paul Slavin
Paul Slavin
Everyday Health hired an ABC News exec to head up its health video and global news efforts.

Paul Slavin, who was SVP for new media at ABC News, in charge of all of the Disney unit's digital content, mobile and broadband communications, becomes SVP general manager, global news and Everyday Health Studios. He assumes responsibility for expanding news operations, including the new Everyday Health Studios video unit, and reports to EVP/chief product officer Goli Sheikholesiami.

“Our commitment to using video to expand our reach to a greater number of health consumers is clearly demonstrated with the addition of paul, who has been instrumental in the digital success of ABC News,” said Sheikholesiami in a statement. “He will play a key role in developing projects such as our new Everyday Health television series and work on other groundbreaking ideas.”

Slavin spent 33 years at ABC News, serving as executive producer of “World News Tonight With Peter Jennings” and SVP worldwide newsgathering before overseeing a shakeup of the New Media business unit that made it profitable. At Everyday Health, he is tasked with bolstering video production across the company's portfolio of brands, including EverydayHealth.com, MedPage Today and DailyGlow.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.